Title:
AGENT FOR INHIBITING HBV-DERIVED CCCDNA, METHOD FOR INHIBITING HBV-DERIVED CCCDNA, MEDICAL COMPOSITION FOR HBV INFECTION, AND METHOD FOR TREATING HBV INFECTION
Document Type and Number:
Japanese Patent JP2023108978
Kind Code:
A
Abstract:
To provide a novel agent for inhibiting cccDNA existing in the nucleus of a cell.SOLUTION: An agent for inhibiting HBV-derived cccDNA includes a ferritin light chain inhibitor to inhibit a ferritin light chain. The ferritin light chain inhibitor is an expression inhibitor to inhibit the expression of the ferritin light chain. A pharmaceutical composition for HBV infection includes the agent for inhibiting HBV-derived cccDNA.SELECTED DRAWING: Figure 1
Inventors:
MURAKAMI YOSHIKI
KURODA MASAHIKO
UMETSU TOMOHIRO
KURODA MASAHIKO
UMETSU TOMOHIRO
Application Number:
JP2022010319A
Publication Date:
August 07, 2023
Filing Date:
January 26, 2022
Export Citation:
Assignee:
UNIV TOKYO MEDICAL
International Classes:
A61K31/7105; A61K31/713; A61K35/76; A61K35/761; A61K45/00; A61K48/00; A61P1/16; A61P31/20; A61P43/00; C07K16/18; C12N15/113; C12N15/63
Attorney, Agent or Firm:
Yumi Nakayama
Previous Patent: DPC receipt inspection system, inspection method and program
Next Patent: Management system, management device and method
Next Patent: Management system, management device and method